Purpose of this Study
We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).
Who Can Participate?
Eligibility
Adults ages 18+ who:
- Are scheduled to have MRI scans
- Have a histological (a microscopic study of the structure of a tumor) diagnosis of primary or metastatic brain tumor
- Are able to speak, read, and write in English
For more information about who can be in this study, please contact the study team at 919-684-5301.
- Are scheduled to have MRI scans
- Have a histological (a microscopic study of the structure of a tumor) diagnosis of primary or metastatic brain tumor
- Are able to speak, read, and write in English
For more information about who can be in this study, please contact the study team at 919-684-5301.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you chose to be in this study, you will:
- Complete a Hospital Anxiety and Depression Scale (HADS) questionnaire before your first MRI scan
- Complete ViSPad (a series of images viewed on an electronic tablet) before your second MRI scan
- Complete HADS after ViSPad and before your second MRI scan
- Complete an Exit Survey after your second MRI scan
- Complete a Hospital Anxiety and Depression Scale (HADS) questionnaire before your first MRI scan
- Complete ViSPad (a series of images viewed on an electronic tablet) before your second MRI scan
- Complete HADS after ViSPad and before your second MRI scan
- Complete an Exit Survey after your second MRI scan
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
A Feasibility Study for Heavy Compression Static Images (ViSPad) for the Reduction of Anxiety, Depression, and Intrusive Memories in Brain Tumor Patients Undergoing Standard of Care Imaging
Principal Investigator
Katherine
Peters
Protocol Number
PRO00110745
Phase
Pilot
Enrollment Status
OPEN TO ACCRUAL